Stock ALTEOGEN INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Alteogen Inc Korea S.E.

Equities

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
- - Intraday chart for Alteogen Inc
2023 Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA CI
2023 ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI

Business Summary

Alteogen Inc. is a Korea-based company mainly engaged in the research and development of biopharmaceuticals. The Company operates biobetter business segment, which develops protein pharmaceuticals and cancer therapies, and bio similar business segment, which develops bio similar and animal medicines. The Company mainly provides growth hormone, herceptin, humira, antibodies, animal drugs and others.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Research Service
86.4 %
8,733 30.3 % 83,399 86.4 % +855.03%
Merchandise
13.4 %
18,733 65.0 % 12,949 13.4 % -30.87%
Transgenic Animal and Plant Development Product
0.2 %
1,341 4.7 % 174 0.2 % -87.01%

Sales per region

KRW in Million2022Weight2023Weight Delta
Overseas
86.4 %
9,092 31.6 % 83,385 86.4 % +817.15%
South Korea
13.6 %
19,715 68.4 % 13,138 13.6 % -33.36%

Managers

Managers TitleAgeSince
Sun-Jae Park CEO
 Chief Executive Officer 69 08-05-12
Sang-Woo Kang DFI
 Director of Finance/CFO 58 20-05-31
Gyu-Wan Kim CTO
 Chief Tech/Sci/R&D Officer 58 -
Seung-Ju Lee CTO
 Chief Tech/Sci/R&D Officer 61 -
Min-Seok Lee IRC
 Investor Relations Contact 61 -
Byung-Kyu Lee AUD
 Comptroller/Controller/Auditor 58 21-03-28
Hye-Sin Jung PRN
 Corporate Officer/Principal 67 08-05-12

Members of the board

Members of the board TitleAgeSince
Sun-Jae Park CEO
 Chief Executive Officer 69 08-05-12
Jong-In Choi BRD
 Director/Board Member 59 21-03-28
In-Young Go BRD
 Director/Board Member 68 21-03-28
Hye-Sin Jung PRN
 Corporate Officer/Principal 67 08-05-12
Sang-Woo Kang DFI
 Director of Finance/CFO 58 20-05-31
Yang-Woo Kim BRD
 Director/Board Member 55 21-03-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 2 0 2 ( 100.00 %) 68.48 %
Stock B 1 53,011,828 36,304,769 ( 68.48 %) 23,706 ( 0.0447 %)

Shareholders

NameEquities%Valuation
Sun-Jae Park
19.25 %
10,206,000 19.25 % 1 497 M
In-Woo Hyung
5.659 %
3,000,000 5.659 % 440 M
KISSEI PHARMACEUTICAL CO., LTD.
1.806 %
957,590 1.806 % 140 M
Hye-Sin Jung
0.7847 %
416,000 0.7847 % 61 M
Soo-min Park
0.5225 %
277,000 0.5225 % 41 M
Sang-mi Lee
0.3878 %
205,583 0.3878 % 30 M
State Street Global Advisors Ltd.
0.1250 %
66,271 0.1250 % 10 M
ALTEOGEN INC.
0.0447 %
23,706 0.0447 % 3 M
PMG Investment Solutions AG
0.0224 %
11,898 0.0224 % 2 M
Korea Investment Management Co., Ltd.
0.0129 %
6,842 0.0129 % 1 M

Holdings

NameEquities%Valuation
ALTEOGEN INC.
0.04%
 23,706 0.04% 3,476,000 $

Company contact information

Alteogen, Inc.

62 Yuseong-daero 1628beon-gil Yuseong-gu

34054, Daejeon

+

http://www.alteogen.com
address Alteogen Inc

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Sector Biopharmaceuticals

1st Jan change Capi.
CSL LIMITED Stock CSL Limited
-5.99% 84.46B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+3.95% 40.85B
BIOGEN INC. Stock Biogen Inc.
-26.37% 27.69B
UCB Stock UCB
+51.01% 24.28B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-6.59% 17.09B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-32.37% 13.67B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-10.45% 11.79B
INCYTE CORPORATION Stock Incyte Corporation
-15.88% 11.86B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
-2.85% 8.07B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. A196170 Stock
  4. Stock
  5. Company Alteogen Inc